The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma
Clinical trial NCT00270101 · COMPLETED
Trial details
- NCT number
- NCT00270101
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-01-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.